Report #2850601

Received Jul 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 16 yrs
State: FL
Recovered: Unknown
Vaccinated: Jul 1, 2025
Onset: Jul 1, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	E4A39	—

Symptoms (1)

Expired product administered

Symptom narrative

Menveo 1 vial less than 30 days expired dose administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 01-JUL-2025, the patient received Menveo. On 01-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo 1 vial less than 30 days expired dose administration). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 11-JUL-2025 A Health Care Provider wanted to know how to proceed after administering an expired dose of Menveo 1 vial (one day after the expiration date) which led to expired vaccine usage.